There are 2789 resources available
1270P - Genomic alterations of bone metastases in stage IV non-small cell lung cancer (NSCLC) and real-world outcomes
Presenter: Pei Jye Voon
Session: ePoster Display
1271P - Molecular driver mutations in never-smokers with lung adenocarcinoma
Presenter: Philip Mack
Session: ePoster Display
1272P - First results of the early onset lung cancer (EOLUNG) study to characterize genomic alterations using FoundationOne CDx in young patients with non-small cell lung cancer
Presenter: Maria Jove Casulleras
Session: ePoster Display
1252P - Liquid biopsy to track KRAS G12C mutation at progressive disease in patients with advanced non-small cell lung cancer (NSCLC)
Presenter: Gianluigi De Renzi
Session: ePoster Display
1274P - An audit of liquid biopsies for NSCLC patients over a 50-month period in a resource constrained setting
Presenter: Navneet Singh
Session: ePoster Display
1275P - Mutational landscape of non-small cell lung carcinoma in patients with different types of premalignant bronchial lesions
Presenter: Tatiana Gerashchenko
Session: ePoster Display
1276P - Deep molecular characterization of never smoker non-small cell lung cancer (NSCLC) patients
Presenter: Chiara Dellepiane
Session: ePoster Display
1277P - Molecular features in young non-small cell lung cancer: A comparative analysis
Presenter: Tongmei Zhang
Session: ePoster Display
1278P - SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, as first-line therapy for PD-L1+ advanced/metastatic NSCLC: Data from a clinical expansion cohort of a phase I study
Presenter: Jifeng Feng
Session: ePoster Display
1279P - The prognostic value of chemotherapy-induced neutropenia (CIN) in patients with advanced non-small cell lung cancer (NSCLC) in the era of chemoimmunotherapy (CIT)
Presenter: Alexander Meisel
Session: ePoster Display